A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold
Trial Parameters
Brief Summary
To further evaluate the efficacy and safety of Antiwei granule in the treatment of common cold (wind-cold syndrome)
Eligibility Criteria
Inclusion Criteria: 1. It met the diagnostic criteria of common cold in western medicine; 2. In accordance with the TCM syndrome differentiation standard of wind-cold syndrome; 3. Male and female patients aged 18 to 65 years; 4. The disease duration at enrollment was ≤48 h; 5. At enrollment, 37.3 ° C ≤axillary temperature \< 38.5 ° C; 6. Informed consent was obtained voluntarily. Exclusion Criteria: 1. Complicated with influenza, pneumonia, suppurative tonsillitis, acute tracheobronchitis, acute pharyngeal conjunctivitis, acute viral or herpetic pharyngitis, acute viral or herpetic laryngitis; 2. Patients who had been infected with 2019-ncov in the past and still had symptoms such as cough and fatigue for nearly 3 months after the antigen turned negative; 3. Primary ciliary dyskinesia syndrome, other acute onset nasal diseases (such as allergic rhinitis, chronic rhinitis, acute and chronic sinusitis, etc.), previous nasal surgery or radiotherapy of the nasopharynx with nasal mucosal dy